Camurus AB (CAMRF)
56.80
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Camurus Revenue (Quarterly): 46.21M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 46.21M |
| June 30, 2024 | 41.71M |
| March 31, 2024 | 37.60M |
| December 31, 2023 | 35.28M |
| September 30, 2023 | 35.60M |
| June 30, 2023 | 64.17M |
| March 31, 2023 | 27.25M |
| December 31, 2022 | 25.09M |
| September 30, 2022 | 23.02M |
| June 30, 2022 | 23.17M |
| March 31, 2022 | 23.65M |
| December 31, 2021 | 20.70M |
| September 30, 2021 | 17.83M |
| June 30, 2021 | 16.40M |
| March 31, 2021 | 15.04M |
| December 31, 2020 | 12.28M |
| September 30, 2020 | 11.33M |
| June 30, 2020 | 8.366M |
| March 31, 2020 | 5.126M |
| December 31, 2019 | 3.648M |
| September 30, 2019 | 4.191M |
| Date | Value |
|---|---|
| June 30, 2019 | 1.261M |
| March 31, 2019 | 2.019M |
| December 31, 2018 | 0.8627M |
| September 30, 2018 | 2.187M |
| June 30, 2018 | 0.8451M |
| March 31, 2018 | 1.806M |
| December 31, 2017 | 0.6559M |
| September 30, 2017 | 1.541M |
| June 30, 2017 | 2.174M |
| March 31, 2017 | 1.926M |
| December 31, 2016 | 4.107M |
| September 30, 2016 | 3.584M |
| June 30, 2016 | 3.147M |
| March 31, 2016 | 2.397M |
| December 31, 2015 | 4.275M |
| September 30, 2015 | 4.386M |
| June 30, 2015 | 2.691M |
| March 31, 2015 | 7.043M |
| December 31, 2014 | 19.50M |
| September 30, 2014 | 4.895M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
3.648M
Minimum
Dec 2019
64.17M
Maximum
Jun 2023
24.67M
Average
23.09M
Median
Revenue (Quarterly) Benchmarks
| Abliva AB | -- |
| Oncopeptides AB | 0.26M |
| BioInvent International AB | 1.23M |
| Hansa Biopharma AB | 4.689M |
| BioArctic AB | 4.673M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 12.46M |
| Total Expenses (Quarterly) | 32.55M |
| EPS Diluted (Quarterly) | 0.2081 |
| Enterprise Value | 3.067B |
| Gross Profit Margin (Quarterly) | 93.01% |
| Profit Margin (Quarterly) | 26.97% |
| Earnings Yield | 0.75% |
| Operating Earnings Yield | 0.81% |
| Normalized Earnings Yield | 0.7521 |